Carlyle Mozart Coinvestment Holdings, L.P. 4

What Happened
Carlyle Mozart Coinvestment Holdings, L.P. (a reported 10% owner) sold 26,105,840 shares of Medline Class A common stock on 2026-03-10 at $41.00 per share, generating proceeds of $1,070,339,440. The filing also reports an additional disposition of 2,113,483 shares via an other disposition code (J); footnotes indicate this was a pro‑rata distribution for no consideration to a limited partner (subject to lock‑up restrictions).

Key Details

• Transaction date(s): 2026-03-10. Sale price: $41.00 per share for the 26,105,840‑share sale. Total reported proceeds: $1,070,339,440.
• Other disposition (J): 2,113,483 shares distributed (no sales proceeds reported); per footnote this was a pro‑rata distribution to a limited partner with lock‑up restrictions.
• Shares held after transactions (Carlyle Mozart Coinvestment Holdings, L.P.): 14,011,611 shares (per filing footnote).
• Insider type: Institutional 10% owner (not an individual executive). Ownership and control flow is detailed through Carlyle‑related entities (see filing footnotes).
• Filing: Form 4 filed 2026-03-12 for a 2026-03-10 transaction — appears timely (filed two days after the trade).

Context
This filing reflects institutional reallocation (large open‑market/private sale plus an in‑kind distribution), not a typical insider executive trade. Purchases generally carry more interpretive weight for bullish signals; large institutional sales or distributions can reflect portfolio or fund‑level decisions rather than views on near‑term company performance. The distributed shares are subject to lock‑up terms per the footnote.